For example, C3b deposited on tumor cells promotes the binding and activation of effector immune cells, including phagocytes and natural killer (NK) cells expressing complement receptor 3 (CR3 -CD11b-CD18), resulting in complement-dependent cell cytotoxicity (CDCC) [7]. This evidence concerns the gene C3 and neoplasm.